Skip Navigation LinksHome > Published Ahead-of-Print > Responses to the McGill Pain Questionnaire Predict Neuropath...
Journal of Lower Genital Tract Disease:
doi: 10.1097/LGT.0000000000000056
Original Article: PDF Only

Responses to the McGill Pain Questionnaire Predict Neuropathic Pain Medication Use in Women in With Vulvar Lichen Sclerosus.

Berger, Mitchell B. MD, PhD; Damico, Nicholas J. BS; Haefner, Hope K. MD

Published Ahead-of-Print
Collapse Box

Abstract

Objective: The goal of this study was to test the hypothesis that responses to the McGill Pain Questionnaire are predictive of adjunctive neuropathic pain medication use by women with lichen sclerosus (LS).

Materials and Methods: This is a retrospective chart review of 430 women with vulvar LS treated at a tertiary referral vulvar care clinic. Demographics, responses to the McGill Pain Questionnaire, and use of neuropathic pain medications were collected. Bivariate and multivariable logistic regression analyses were performed to identify factors significantly associated with use of neuropathic pain medications.

Results: Of the 430 subjects, 119 (27.7%) used neuropathic pain medications for vulvar pain. Factors significantly associated with use of these medications include lower body mass index (odds ratio [OR] = 0.96, p = .02), non-White race (OR = 2.97, p = .05), and total McGill Pain Questionnaire score (OR = 1.05, p < .001).

Conclusions: Vulvar pain is a common presenting symptom in women with LS. Responses to the McGill Pain Questionnaire may be helpful in the long-term management of women with LS as a screen to identify those patients who might benefit from adjunctive neuropathic pain medication use.

Copyright (C) 2014 by the American Society for Colposcopy and Cervical Pathology

Login

Article Tools

Share

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.